niacinamide has been researched along with von Hippel-Lindau Disease in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
von Hippel-Lindau Disease: An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The recent contributions to renal cell carcinoma in the fields of molecular biology and the expanded use of molecularly targeted agents will be reviewed." | 2.44 | Renal cell carcinoma. ( Godley, P; Rathmell, WK; Rini, BI, 2008) |
| "Patients with metastatic clear cell renal cell carcinoma with available baseline tumor samples who received vascular endothelial growth factor targeted therapy were included in analysis." | 1.35 | von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma. ( Bhalla, IP; Bukowski, RM; Choueiri, TK; Elson, P; Ganapathi, R; Golshayan, AR; Jaeger, E; Rini, BI; Sein, N; Sercia, L; Simko, J; Small, EJ; Vaziri, SA; Waldman, FM; Weinberg, V; Wood, L; Zhou, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choueiri, TK | 1 |
| Vaziri, SA | 1 |
| Jaeger, E | 1 |
| Elson, P | 1 |
| Wood, L | 1 |
| Bhalla, IP | 1 |
| Small, EJ | 1 |
| Weinberg, V | 1 |
| Sein, N | 1 |
| Simko, J | 1 |
| Golshayan, AR | 1 |
| Sercia, L | 1 |
| Zhou, M | 1 |
| Waldman, FM | 1 |
| Rini, BI | 2 |
| Bukowski, RM | 1 |
| Ganapathi, R | 1 |
| Mellado, B | 1 |
| Gascón, P | 1 |
| Vira, MA | 1 |
| Novakovic, KR | 1 |
| Pinto, PA | 1 |
| Linehan, WM | 1 |
| Rathmell, WK | 1 |
| Godley, P | 1 |
3 reviews available for niacinamide and von Hippel-Lindau Disease
| Article | Year |
|---|---|
Molecular biology of renal cell carcinoma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic A | 2006 |
Genetic basis of kidney cancer: a model for developing molecular-targeted therapies.
Topics: Adult; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Humans; Indoles; Kidne | 2007 |
Renal cell carcinoma.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzen | 2008 |
1 other study available for niacinamide and von Hippel-Lindau Disease
| Article | Year |
|---|---|
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopla | 2008 |